NO20002487D0 - Preparat med azelainsyre - Google Patents

Preparat med azelainsyre

Info

Publication number
NO20002487D0
NO20002487D0 NO20002487A NO20002487A NO20002487D0 NO 20002487 D0 NO20002487 D0 NO 20002487D0 NO 20002487 A NO20002487 A NO 20002487A NO 20002487 A NO20002487 A NO 20002487A NO 20002487 D0 NO20002487 D0 NO 20002487D0
Authority
NO
Norway
Prior art keywords
azelaic acid
preparation
composition
presbyderma
triacylglyceride
Prior art date
Application number
NO20002487A
Other languages
English (en)
Other versions
NO327712B1 (no
NO20002487L (no
Inventor
Patrick Franke
Clemens Guenther
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27217979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20002487D0 publication Critical patent/NO20002487D0/no
Publication of NO20002487L publication Critical patent/NO20002487L/no
Publication of NO327712B1 publication Critical patent/NO327712B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20002487A 1997-11-19 2000-05-12 Azelainsyreholdig preparat og anvendelse derav NO327712B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19753044 1997-11-19
US7485098P 1998-02-12 1998-02-12
DE19808086 1998-02-20
PCT/EP1998/007370 WO1999025332A1 (de) 1997-11-19 1998-11-18 Zusammensetzung mit azelainsäure

Publications (3)

Publication Number Publication Date
NO20002487D0 true NO20002487D0 (no) 2000-05-12
NO20002487L NO20002487L (no) 2000-07-18
NO327712B1 NO327712B1 (no) 2009-09-14

Family

ID=27217979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002487A NO327712B1 (no) 1997-11-19 2000-05-12 Azelainsyreholdig preparat og anvendelse derav

Country Status (21)

Country Link
US (1) US6534070B1 (no)
EP (1) EP1032379B1 (no)
JP (1) JP3867123B2 (no)
KR (1) KR100534511B1 (no)
AT (1) ATE210438T1 (no)
AU (1) AU743437B2 (no)
BR (1) BR9814214B1 (no)
CA (1) CA2311128C (no)
CZ (1) CZ299116B6 (no)
DE (2) DE59802473D1 (no)
DK (1) DK1032379T3 (no)
ES (1) ES2169566T3 (no)
HU (1) HU226592B1 (no)
IL (1) IL136101A (no)
IS (1) IS2257B (no)
NO (1) NO327712B1 (no)
PL (1) PL202454B1 (no)
PT (1) PT1032379E (no)
SK (1) SK284338B6 (no)
TR (1) TR200001393T2 (no)
WO (1) WO1999025332A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE369866T1 (de) * 2003-06-10 2007-09-15 Intendis Gmbh Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
US20050026982A1 (en) * 2003-06-10 2005-02-03 Soenke Johannsen Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
DE10356288B4 (de) 2003-11-28 2014-04-03 Siemens Aktiengesellschaft Röntgendetektorlade
CA2600054A1 (en) * 2005-03-09 2006-09-21 Combe Incorporated Stable mixed emulsions
CA2600288A1 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2201930A1 (en) * 2008-12-23 2010-06-30 Intendis GmbH Hydrogel composition for the treatment of dermatological disorders
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
PL217786B1 (pl) * 2009-05-28 2014-08-29 P P F Hasco Lek Spółka Akcyjna Żel z kwasem azelainowym i sposób wytwarzania żelu z kwasem azelainowym
GB2486371A (en) 2009-08-21 2012-06-13 Targeted Delivery Technologies Ltd Vesicular formulations
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
GB201205642D0 (en) * 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
GB201208409D0 (en) * 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, kits and uses
ES2895910T3 (es) 2015-06-30 2022-02-23 Sequessome Tech Holdings Limited Composiciones multifásicas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
CN116747147B (zh) * 2023-04-27 2025-10-17 南京市苗本堂健康管理有限公司 一种靶向祛痘的壬二酸微纳晶混悬液及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
EP0510165B1 (fr) * 1990-11-14 1995-01-25 L'oreal Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
GB9316323D0 (en) * 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5547989A (en) 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado

Also Published As

Publication number Publication date
KR20010032229A (ko) 2001-04-16
BR9814214B1 (pt) 2010-07-13
PT1032379E (pt) 2002-06-28
ES2169566T3 (es) 2002-07-01
CZ299116B6 (cs) 2008-04-30
JP2001522879A (ja) 2001-11-20
HU226592B1 (en) 2009-04-28
DK1032379T3 (da) 2002-04-02
CZ20001844A3 (cs) 2000-10-11
NO327712B1 (no) 2009-09-14
KR100534511B1 (ko) 2005-12-08
TR200001393T2 (tr) 2000-10-23
AU1755199A (en) 1999-06-07
CA2311128C (en) 2008-01-29
EP1032379A1 (de) 2000-09-06
US6534070B1 (en) 2003-03-18
DE59802473D1 (de) 2002-01-24
IL136101A (en) 2005-08-31
JP3867123B2 (ja) 2007-01-10
BR9814214A (pt) 2000-10-03
HUP0004375A2 (hu) 2001-08-28
IS5484A (is) 2000-05-09
CA2311128A1 (en) 1999-05-27
PL202454B1 (pl) 2009-06-30
WO1999025332A1 (de) 1999-05-27
EP1032379B1 (de) 2001-12-12
SK284338B6 (sk) 2005-02-04
AU743437B2 (en) 2002-01-24
NO20002487L (no) 2000-07-18
PL340631A1 (en) 2001-02-12
SK7082000A3 (en) 2001-06-11
DE19881737D2 (de) 2001-03-22
IS2257B (is) 2007-06-15
IL136101A0 (en) 2001-05-20
ATE210438T1 (de) 2001-12-15
HUP0004375A3 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
NO20002487D0 (no) Preparat med azelainsyre
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
ID26773A (id) Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya
BR0003897A (pt) Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
DK261490D0 (da) New pharmaceutical compound
BRPI0414215A (pt) tienopirazóis
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
EA200000176A1 (ru) Применение физиологически приемлемых соединений, солей и комплексов ванадия
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
ITBO930059A1 (it) Procedimento per ottenere la rigenerazione dei tessuti nella terapia odontoiatrica parodentale.
EP1090635A3 (en) Use of ferulic acid for treating hypertension
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
PT1208078E (pt) Sais nao higroscopicos de substancias activas com actividades terapeuticas e/ou nutricionais e composicoes passiveis de serem administradas oralmente contendo os mesmos
MY129121A (en) Composition with azelaic acid
WO2000010590A3 (en) Cancer treatment
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
EP1106177A4 (en) AGENTS FOR INCREASING MEDICINE ACCUMULATION IN TUMOR TISSUES
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
ITMI950625A0 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche

Legal Events

Date Code Title Description
MK1K Patent expired